Digitek FAQ

The following are answers to the most frequently asked questions (faq) regarding the Digitek recall

Q: Why is Actavis recalling Digitek (digoxin)?
A: This voluntary all-lot recall is due to the possibility that some tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than is appropriate.

Q: What should I do if I’m taking Digitek (digoxin)?
A: Patients should contact their physician to get a new prescription. All inquiries related to returning your product or the recall should be addressed to Stericycle customer service.

Q: What should I do if I was seriously injured as a result of Digitek?
A: You should contact an attorney to review your legal options as soon as possible. While product liability laws vary by state, you have a very limited time in which to file a claim against the manufacturer. If you have legal questions, you may contact Beasley Allen for a free legal consultation.

Q: How can I report serious side effects from, or reactions to, Digitek (digoxin)?
A: If you wish to report an adverse experience from taking digoxin, you are directed to select option “3” from the menu provided on the Stericycle answering service where you will be directed to an Actavis representative who will process your information.

You may also report adverse side effects via the FDA’s online reporting form.

If you need medical attention or have any inquiries regarding your treatment, however, you should contact your physician.

Q: What is Digitek (digoxin)?
A: Digitek is the brand name for digoxin tablets, USP 0.125 mg and 0.25 mg, manufactured by Actavis and distributed by Mylan Pharmaceuticals, Inc. under the Bertek and UDL labels. It is prescribed for oral use to treat heart failure and abnormal heart rhythms.

Q: Where is Digitek (digoxin) manufactured?
A: Digitek is manufactured in the United States by Actavis Totowa, in New Jersey.

Q: Is the recall just in the United States, or also in other countries?
A: The recall is only in the United States.